INS and Hypoglycemia: In addition, a post hoc analysis of data from 2 of thephase 2 studies also found that hypoglycemia duration was similar with icodec comparedto IGlar U100 in insulin-naive and insulin-treated patients with T2D, regardless oftitration algorithm or use of a loading dose (114).